Poseida Therapeutics Presents Novel BCMA-Specific CAR-T Therapy at CAR-TCR Summit – Markets Insider
|
Poseida Therapeutics Presents Novel BCMA-Specific CAR–T Therapy at CAR-TCR Summit
Markets Insider SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving cell therapies, today presented preclinical data on P-BCMA-101, the … |
|
CAR–T
STAT CAR-T is short for chimeric antigen receptor T–cell. CAR-T therapies could be considered a subset of immunotherapy. They’re also a subset of cellular therapies. (But not of gene therapy, some biotech types have 2 loudly 3 declared 4.) Here’s how they … |
|
Gene therapy to treat ‘Lorenzo’s Oil’ disease
Independent Online Doctors have for the first time successfully used gene therapy to treat children with a rare disease of the nervous system that gained worldwide recognition thanks to the Hollywood movie Lorenzo’s Oil, a European health group said. The European … |